The pathogenic role of inflammation in multiple sclerosis;El significado patogenico de la inflamacion en la esclerosis multiple

Revista de Neurologia

Volumn 30, Issue 12, 2000, Pages 1213-1217

  Martino, G ^a   Furlan, R ^a   Poliani, P L ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Cytokines; Glial cells; Inflammation; Inflammatory mediators; Multiple sclerosis; T cells

Indexed keywords

CYTOKINE; AUTACOID;

ANTIGEN SPECIFICITY; CONFERENCE PAPER; DEMYELINATION; EFFECTOR CELL; GLIA CELL; HUMAN; INFLAMMATION; MACROPHAGE ACTIVATION; MEDIATOR RELEASE; MULTIPLE SCLEROSIS; PATHOGENESIS; T LYMPHOCYTE ACTIVATION; BRAIN; GLIA; METABOLISM; PATHOLOGY; REVIEW; T LYMPHOCYTE;

BRAIN; CYTOKINES; HUMANS; INFLAMMATION MEDIATORS; MULTIPLE SCLEROSIS; NEUROGLIA; T-LYMPHOCYTES;

EID: 0034674115     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3012.99474     Document Type: Conference Paper

References (42)

1. Cotran RS, Kumar V, Robbins SL. Pathologic basis of disease. Philadelphia: WB Saunders; 1994.
2. Sacca R, Cuff CA, Ruddle NH. Mediators of inflammation. Curr Opin Immunol 1997; 9: 851-7.
3. Brouckaert P, Libert C, Everaerdt B, Takahashi N, Cauwels A, Fiers W. Tumor necrosis factor, its receptors and the connection with interleukin 1 and interleukin 6. Immunobiology 1993; 187: 317-29.
4. Luster AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-45.
5. Kremlev SG, Chapoval AI, Evans R. Cytokine release by macrophages after interacting with CSF-1 and extracellular matrix proteins: characteristics of a mouse model of inflammatory responses in vitro. Cell Immunol 1998; 185: 59-64.
6. Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes. Nature 1996; 383: 787-93.
7. Chomarat P, Banchereau J. An update on interleukin-4 and its receptor. Eur Cytokine Netw 1997; 8: 333-44.
8. Martino G, Hartung HP. Immunopathogenesis of multiple sclerosis: the role of T cells. Curr Opin Neurol 1999: 12; 309-21.
9. Steinman L. A few autoreactive cells in an autoimmune infiltrate control a vast population of non specific cells: a tale of smart bombs and the infantry. Proc Natl Acad Sci USA 1996; 93: 2253-6.
10. Lassmann H, Bruck W, Lucchinetti CF, Rodríguez M. Remyelination in multiple sclerosis. Multiple Sclerosis 1997; 3: 133-6.
11. Lucchinetti CF, Bruck W, Rodríguez M, Lassmann H. Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol 1996; 6: 259-74.
12. Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM. Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell 1993; 72: 551-60.
13. Lafaille JJ, Nagashima K, Katsuki M, Tonegawa S. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient antimyelin basic protein T cell receptor transgenic mice. Cell 1994; 78: 399-408.
14. Esiri MM, Gay D. The immunocytochemistry of multiple sclerosis plaques. In Raine CS, McFarland HF, Tourtellotte WW, eds. Multiple sclerosis. Clinical and pathogenetic basis. London: Chapman & Hall; 1997. p. 173-86.
15. Karpus WJ, Ransohoff RM. Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J Immunol 1998; 161: 2667-71.
16. Battistini L, Borsellino G, Sawicki G, Poccia F, Salvetti M, Ristori G, et al. Phenotypic and cytokine analysis of human peripheral blood gamma delta T cells expressing NK cell receptors. J Immunol 1997; 159: 3723-30.
17. Newcombe J, Li H, Cuzner ML. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques: implications for pathogenesis. Neuropathol Appl Neurobiol 1994; 20: 152-62.
18. Huterer SJ, Tourtellotte WW, Wherrett JR. Alterations in the activity of phospholipases A2 in postmortem white matter from patients with multiple sclerosis. Neurochem Res 1995; 20: 1335-43.
19. Narayana PA, Doyle TJ, Lai D, Wolinsky JS. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis. Ann Neurol 1998; 43: 56-71.
20. Cuzner ML, Gveric D, Strand C, Loughlin AJ, Paemen L, Opdenakker G, et al. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: comparison of stages in lesion evolution. J Neuropathol Exp Neurol 1996; 55: 1194-204.
21. Li H, Cuzner ML, Newcombe J. Microglia-derived macrophages in early multiple sclerosis plaques. Neuropathol Appl Neurobiol 1996; 22: 207-15.
22. Selmaj KW, Raine CS, Cannella B, Brosnan CF. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 1991; 87: 949-54.
23. Filippi M, Rocca MA, Martino G, Horshfield MA, Comi G. Magnetization transfer changes in the normal-appearing white matter precede the appearance of enhancing lesions in patients with multiple sclerosis. Ann Neurol 1998; 43: 809-14.
24. Soderstrom M, Link H, Sun JB, Fredrikson S, Wang ZY, Huang WX. Autoimmune T cell repertoire in optic neuritis and multiple sclerosis: T cells recognizing multiple myelin proteins are accumulated in cerebrospinal fluid. J Neurol Neurosurg Psychiatry 1994; 57: 544-51.
25. Chou YK, Vainiene M, Whitham R, Bourdette D, Chou CH, Hashim G, et al. Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules. J Neurosci Res 1989; 23: 207-16.
26. Trotter JL, Hickey WF, van der Veen RC, Sulze L. Peripheral blood mononuclear cells from multiple sclerosis patients recognize myelin proteolipid protein and selected peptides. J Neuroimmunol 1991; 33: 55-62.
27. Sun J, Link H, Olsson T, Xiao BG, Andersson G, Ekre HP, et al. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis. J Immunol 1991; 146: 1490-5.
28. Olsson T, Zhi WW, Hojeberg B, Kostulas V, Jiang YP, Anderson G, et al. Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. J Clin Invest 1990; 86: 981-5.
29. Link H, Sun JB, Wang Z, Xu Z, Love A, Fredrikson S, et al. Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis. J Neuroimmunol 1992; 38: 63-73.
30. Sun JB, Olsson T, Wang WZ, Xiao BG, Kostulas V, Fredrikson S, et al. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls. Eur J Immunol 1991; 21: 1461-8.
31. Voskuhl RR, Martin R, Bergman C, Dalal M, Ruddle NH, McFarland HF. T helper 1 (Th1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 1993; 15: 137-43.
32. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS, et al. Selection for T-cell receptor V beta-D beta-J beta gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993; 362: 68-70.
33. Martino G, Consiglio A, Franciotta DM, Corti A, Filippi M, van den Broeck K, et al. Tumor necrosis factor α and its receptors (R1 and R2) in relapsing-remitting multiple sclerosis. J Neurol Sci 1997; 152: 51-61.
34. Burns J, Rosenzweig A, Zweiman B, Lisak RP. Isolation of myelin basic protein-reactive T-cell lines from normal human blood. Cell Immunol 1983; 81: 435-40.
35. Martino G, Grohovaz F, Brambilla E, Codazzi F, Consiglio A, Clementi E, et al. Proinflammatory cytokines regulate antigen-independent T-cell activation by two separate calcium-signaling pathways in multiple sclerosis patients. Ann Neurol 1998; 43: 340-9.
36. Mein LE, Hoch RM, Dornmair K, de Waal Malefyt R, Bontrop RE, Jonker M, et al. Encephalitogenic potential of myelin basic protein-specific T cells isolated from normal rhesus macaques. Am J Pathol 1997; 150: 445-53.
37. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol 1997; 15: 749-95.
38. Unutmaz D, Pileri P, Abrignani S. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 1994; 180: 1159-64.
39. Tough DF, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 1996; 272: 1947-50.
40. 2+ influx in T lymphocytes from patients with multiple sclerosis. Proc Natl Acad Sci USA 1994; 91: 4825-9.
41. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transition in the lesions of multiple sclerosis. N Eng J Med 1998; 338: 278-85.
42. Van den Broeck K, Martino G, Marrosu M, Consiglio A, Zaffaroni M, et al. Occurrence and clinical relevance of an interleukin-4 gene polymorphism in patients with multiple sclerosis. J Neuroimmunol 1997; 76: 189-92.